baber/WOPTO huggingface dataset:
Patent AU-534010-B2 (AU)
Title: Linolenic and dihomolinolenic acid compositions
Inventor: HORROBIN DAVID FREDERICK
IPC: A23L33/15
Filed: 1980-05-16
Granted: 1983-12-22
Abstract: Composition and use of  gamma -linolenic acid and related materials with ascorbic acid, or ethyl alcohol, or an opiate antagonist such as naloxone, nalorphine or levallorphan, for treating alcoholism or moderating the effects of taking alcohol.
Patent AU-527760-B2 (AU)
Title: Removal of catalyst residues from polymers
Inventor: DIETZ RICHARD EWALDUS
IPC: C08F6/28
Filed: 1980-06-26
Granted: 1983-03-24
Abstract: Polymer containing catalyst residues from catalysts having at least one atom of halide are contacted with a treating agent comprising in combination a monoalkyl ether of a glycol and an alkylene oxide to reduce the level of catalyst residues in the polymer.
Patent AU-569663-B2 (AU)
Title: Exchange with various-mode terminals
Inventor: MUYSSEN JOHN
IPC: H04Q3/545
Filed: 1986-07-30
Granted: 1988-02-11
Abstract: Terminal devices of different operating mode can be, for example, the subscriber station and the attendant's console. Compared with the subscriber station, the latter can fulfil additional switching functions. For these operating modes, terminal devices of the same or different type of construction can be used. A normal telephone station can be set up as an attendant's console by operational inputs. Having regard to the switching processes, there is a unit (TK, VTK) accessible to the central processor (ZSt) for every operating mode. In this unit, the programs are in each case stored which relate to all sequences possible for one operating mode. The programs of this higher program level are called up by another unit (ZK) depending on corresponding stimuli of a terminal device. This unit decouples the device-dependent area from the actual program area. An information on which of the two existing units (TK or VFK) is responsible is transmitted. This thus means that with a stimulus coming from an attendant's console telephone, the determining program component (VFK) for this is activated and with a stimulus coming from a normal telephone station the component (TK) allocated to such a terminal device is activated. The interposed unit (ZK) thus flexibly couples several different terminal devices to several different logic components. <IMAGE>
Patent AU-590896-B2 (AU)
Title: Improved formulations for recombinant beta-interferon
Inventor: HANISCH WOLFGANG HELMUT
IPC: A61K38/00
Filed: 1986-09-12
Granted: 1989-11-23
Abstract: An improved process for recovering and purifying recombinant beta-interferon from its host yields a beta-interferon preparation which may be formulated into a stable pharmaceutical composition having a therapeutically effective amount of the biologically active recombinant beta-interferon dissolved in a non-toxic, inert, therapeutically compatible aqueous-based carrier medium at a pH of 2 to 4 which medium also contains a stabilizer for the recombinant beta-interferon, such as human serum albumin, normal serum albumin and human plasma protein fraction.
Patent AU-771311-B2 (AU)
Title: Branched maltodextrins and method of preparing them
Inventor: FOUACHE CATHERINE
IPC: A23L1/09
Filed: 1999-12-03
Granted: 2004-03-18
Abstract: Branched maltodextrins (I) having 22-35% of 1-6 glucoside linkages, a reducing sugar content of less than 20%, a polymolecularity index (Mw/Mn) of less than 5 and a number-average molecular weight (Mn) of up to 4500 are new. Independent claims are also included for: (1) an acariogenic composition comprising (I) and at least one polyol; (2) a process for preparing (I), comprising: (a) preparing an acidified starch with a moisture content below 5%; (b) heating the starch in a continuous thin-film reactor at 120-300 degrees C; (c) recovering, purifying and preferably concentrating the resulting branched starch derivatives; and (d) fractionating the starch derivatives according to Mn.
Patent AU-762373-B2 (AU)
Title: Method for monitoring proteasome inhibitor drug action
Inventor: VADDI GOPALAKRISHNA R
IPC: C12Q1/37
Filed: 1999-10-19
Granted: 2003-06-26
Abstract: The invention relates to methods for measuring proteasome activity in biological samples. More particularly, then invention relates to methods for monitoring drug action following in vivo administration of a proteasome inhibitor. The invention provides methods and kits for monitoring pharmacodynamic drug action and for determining dose regimen for a proteasome inhibitor. The invention also provides methods for determining baseline proteasome activity in a mammal.
Patent AU-779589-B2 (AU)
Title: Patch bag with patch containing high and low crystallinity ethylene copolymers
Inventor: MUDAR KIMBERLY ANN
IPC: B65D75/00
Filed: 2000-10-24
Granted: 2005-02-03
Abstract: A patch bag has a heat-shrinkable patch adhered to a heat-shrinkable bag. The patch comprises an ethylene/alpha-olefin copolymer having a density greater than about 0.915 g/cm<3>, this copolymer being present in the patch in an amount of at least about 5 percent, based on a total patch weight. The patch also comprises a heterogeneous ethylene/alpha-olefin copolymer having a density of less than about 0.915 g/cm<3>, which is also present in the patch in an amount of at least about 5 percent, based on total patch weight. In addition, the two ethylene/alpha-olefin copolymers make up at least 70 percent of the total patch weight. VLDPE is a preferred heterogeneous ethylene/alpha-olefin less than 0.915 g/cc, and LLDPE is a preferred ethylene/alpha-olefin greater than 0.915 g/cc. The patch film can be selected to exhibit a total free shrink and/or bone-puncture resistance which is higher than either VLDPE or LLDPE alone. The patch film can be selected to exhibit Standard Rib Drop Test results (i.e., puncture-resistance in actual use) superior to other patch bags. <IMAGE>
Patent AU-669300-B2 (AU)
Title: Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis
Inventor: REMINGTON JACK S
IPC: A61K31/395
Filed: 1994-04-29
Granted: 1996-05-30
Abstract: A method of reducing the severity of toxoplasmosis resulring from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Patent AU-715915-B2 (AU)
Title: Osteosynthetic material, composited implant material, and process for preparing the same
Inventor: SHIKINAMI YASUO
IPC: A61B17/58
Filed: 1996-09-13
Granted: 2000-02-10
Abstract: A high bending strength and high density material for osteosynthesis, which comprises a biodegradable and bioabsorbable crystalline thermoplastic polymer material, and a high strength implant material, comprising a composite material in which a bioceramics powder of from 0.2 to 50  mu m in particle size is dispersed in the polymer material, wherein crystals of the polymer material are pressure-oriented not in a uni-axial direction but basically in parallel with a plurality of reference axes; and a production method by pressure orientation, which comprises preparing in advance a biodegradable and bioabsorbable crystalline thermoplastic polymer material or a dispersed mixture of the polymer material and a bioceramics powder and melt-molding it into a pre-molded material which is then press-charged at a cold temperature into a cavity of a closed type forming mold, thereby obtaining an oriented molding. Since the osteosynthesis and implant materials are dense and high strength oriented moldings having less anisotropy in which crystals are oriented in parallel with a plurality of reference axes, excellent ideal biomaterials can be provided which have appropriate hydrolysis property, can maintain sufficient strength during a period required for bone union and are degraded and absorbed at such a rate that they do not induce inflammatory reactions after healing of the fractured bones so that re-operation is not required. <IMAGE>
Patent AU-753661-B2 (AU)
Title: A method for the characterisation of nucleic acid molecules involving generation of extendible upstream DNA fragments resulting from the cleavage of nucleic acid at an abasic site
Inventor: MCCARTHY THOMAS VALENTINE
IPC: C12Q1/6827
Filed: 1998-04-22
Granted: 2002-10-24
Abstract: The present invention is drawn to a method for characterising nucleic acid molecules, which comprises the steps of: i) introducing a modified base which is a substrate for a DNA glycosylase into a DNA molecule; ii) excising the modified base with the DNA glycosylase to generate an abasic site; iii) cleaving the DNA at the abasic site to generate and release an extendible upstream DNA fragment having a 3' hydroxyl terminus; and iv) incubating the released extendible upstream DNA fragment in the presence of an enzyme allowing for extension thereof and an additional template nucleic acid and analysing resultant fragment(s).
Patent AU-679766-B2 (AU)
Title: Magnesium omeprazole
Inventor: KALLSTROM LARS AKE
IPC: A61K9/14
Filed: 1994-07-08
Granted: 1997-07-10
Abstract: A novel compound form of magnesium omeprazole, i.e. with a degree of crystallinity which is higher than 70% as determined by x-ray powder diffraction, useful in the manufacture of pharmaceutical formulations, the use of the product and the process for its production are described.
Patent AU-658137-B2 (AU)
Title: Carbon-containing odor controlling compositions
Inventor: KARAPASHA NANCY
IPC: A61L15/18
Filed: 1991-01-31
Granted: 1995-04-06
Abstract: Compositions comprise carbon particles combined with white odor-controlling agents by means of binders. The preferred particle form of the compositions is substantially lighter in color than the original carbon, and the resulting particles are preferred for use in the manufacture of catamenials, diapers, bandages, and the like. Particles comprising carbon and zeolites are not only desirably lighter in color, but also control a broad spectrum of malodors associated with body fluids.
Patent AU-677419-B2 (AU)
Title: Sphagnum moss composition for the production of sheeted absorbent and method for evaluating the potential of sphagnum moss material for absorbing liquid
Inventor: LEVESQUE YVON
IPC: A61L15/40
Filed: 1994-09-23
Granted: 1997-04-24
Abstract: A method for selectively harvesting vegetable raw material from a sphagnum moss growing site for use in manufacturing liquid-absorbent structures, said growing site containing an aggregate of sphagnum moss species that predominantly belong to a group of botanical sections consisting of PALUSTRIA, ACUTIFOLIA, RIGIDA, SUBSECUNDA and CUSPIDATA.
Patent AU-545672-B2 (AU)
Title: Solar heater system and valve
Inventor: SCHOENHEIMER MARCUS F
IPC: G05D23/02
Filed: 1981-08-19
Granted: 1985-07-25
Abstract: A solar heating system includes an absorber panel (1) connected to a water supply tank. A valve (10,11) is located in each of feed and exhaust connections (3,6) and at least the inlet valve (10) is temperature responsive so as to close when the temperature of the panel contents falls below a first predetermined temperature. The outlet valve (11) may be temperature or flow responsive so as to close under the temperature or flow conditions prevailing when the inlet valve (10) closes and thereby isolate the panel (1) from the tank (2). A temperature responsive dump valve which may be incorporated in the valve (10) is connected to the panel (1) and opens when the temperature of the panel contents falls below a second predetermined temperature which is lower than the first predetermined temperature and thereby empties the panel contents. The combined inlet and dump valve (10) has a temperature responsive element which controls both a primary valve member and a secondary valve member. The primary valve member controls flow between inlet and outlet ports (13,14) of the valve (10) and the secondary valve member controls flow between the outlet port (14) and a dump port (12). The temperature responsive element has a part exposed externally of the valve body and is substantially insulated against the influence of temperature conditions existing within the body of the valve (10).
Patent AU-589534-B2 (AU)
Title: Alumina hydrates
Inventor: BROWN STEPHEN CLIFFORD
IPC: C01F7/023
Filed: 1987-07-14
Granted: 1989-10-12
Abstract: Alumina hydrate particles have a high surface area and low dispersity and may have a low soluble soda content. They may be made by milling a liquid suspension of alumina hydrate, subjecting the milled suspension to classification into coarse and fine fractions, recycling the coarse fraction to the mill and recycling the fine fraction to the classification stage. A narrow particle size distribution is obtained.
Patent AU-653520-B2 (AU)
Title: Cold recoverable elastomeric sleeve and method for installation and use
Inventor: CHANG RON JONG
IPC: B29C63/42
Filed: 1991-04-12
Granted: 1994-10-06
Abstract: A method for covering a substrate comprising the steps of: positioning over the substrate an assembly including a recoverable elastomeric sleeve and a mandrel upon which the sleeve is mounted under tension in an expanded condition such that upon release of the tension the sleeve tends to assume a smaller cross-sectional dimension and thereupon cover the substrate; the mandrel having a generally tubular configuration and defining a series of spaced apart, substantially longitudinal projections extending radially outwardly, the sleeve being in substantial contact with the longitundinal projections; and, withdrawing the mandrel from the sleeve by sliding the mandrel longitudinally away from the sleeve while maintaining its position over the workpiece, the sleeve thereby progressively assuming a smaller cross-sectional dimension to cover the substrate as the mandrel is progressively withdrawn. The substrate may be a high voltage termination or cable splice, and the mandrel may include a medial annular transverse tearline enabling breaking and separation of the mandrel into two segments for facilitating withdrawal from, and recovery of, the sleeve. A lubricating agent may be placed between the longitudinal projections. The sleeve may be provided with end segments which avoid contact with the lubricating agent and which are unfolded following release of the sleeve onto the substrate thereby to seal the ends thereof.
Patent AU-551481-B2 (AU)
Title: Curable fiber reinforced molding composition
Inventor: DOMEIER LINDA ANN
IPC: C08G18/63
Filed: 1981-11-23
Granted: 1986-05-01
Abstract: Curable molding compositions comprising a mixture of: I. from about 25 to about 90 weight percent of a thermosetting resin containing: (a) from about 5 to about 95 weight percent of a polyester resin derived from the reaction of a poly(acrylate) and a vinyl monomer, said poly(acrylate) and vinyl monomer essentially free from functional groups reactive with the polyol of the polyisocyanate of (b); (b) from about 95 to about 5 weight percent of a polyurethane derived from the reaction of a saturated polyol and a polyisocyanate, said polyol and polyisocyanate free from unsaturated groups capable of copolymerizing with the poly(acrylate) or vinyl monomer of (a); and II. from about 75 to about 10 weight percent of one or more fibers with a melting point or a glass transition temperature above about 130 DEG C; wherein (b) constitutes less than 40 weight percent of (I) and (II). These compositions are especially suited to produce thermoset fiber-reinforced molded articles by rapid injection molding techniques.
Patent AU-677443-B2 (AU)
Title: Guiding catheter
Inventor: AAZAM NUSAYR
IPC: A61L29/00
Filed: 1994-11-01
Granted: 1997-04-24
Abstract: The invention provides a catheter comprising:   (a) an elongate proximal tube having a proximal end and a distal end;   (b) a stem transition sleeve having a proximal end and a tapered distal end with its proximal end connected to the distal end of the elongate proximal tube; and (c) a stem sleeve with a complementary tapered proximal portion bonded to the distal end of the stem transition sleeve; wherein the material forming the stem transition sleeve is harder than the material forming the stem sleeve. <IMAGE>
Patent AU-618941-B2 (AU)
Title: Dual bed heat pump
Inventor: SHELTON SAMUEL V
IPC: F25B29/00
Filed: 1987-09-04
Granted: 1992-01-16
Abstract: A heat pump method and system with a pair of solid adsorbent beds connected to a heat pump loop and a reversible heat transfer loop. The heat transfer loop has a heater connected between one end of the beds and a cooling heat exchange connects the other end of the beds so that a heat transfer fluid flowing around the heat transfer loop heats one bed and cools the other.
Patent AU-740249-B2 (AU)
Title: Hair cutting method and device
Inventor: BISSON FRANK PETER
IPC: B26B21/08
Filed: 1998-06-19
Granted: 2001-11-01
Abstract: The invention concerns both a method and device for cutting hair. The device includes a multi-faceted cutting means (10) and a handle (20). The cutting means (10) is preferably formed from a broken piece of glass, preferably having a ragged broken edge to form a multi-faceted cutter with a plurality of cutting edges (13) distributed across it. Having cutting edges (13) distributed in this way, has been found to advantageously provide hair styling effects which give good texture to a hair cut and provide natural build.
Patent AU-740653-B2 (AU)
Title: Plants with controlled side-shoot formation and/or controlled abscission area formation
Inventor: THERES NIKOLAUS
IPC: C12N15/29
Filed: 1998-04-15
Granted: 2001-11-08
Abstract: Disclosed are nucleotide sequences coding polypeptides which are responsible for controlling side-shoot formation and/or petal formation and/or abscission area formation, in addition to polypeptide and amino acid sequences coded by nucleotide sequences. Disclosed are also plants with controlled side-shoot formation and/or petal formation and/or controlled formation of abscission areas, wherein the expressible DNA sequence, fragment or derivative thereof responsible for side-shoot formation and/or petal formation and/or abscission area formation is integrated in a stable manner into the genome of the plant cell or the plant tissue. Further disclosed are methods for the production of plants with controlled side-shoot formation and/or petal formation and/or controlled formation of abscission areas, wherein the expressible DNA sequence or fragment or derivative thereof responsible for side-shoot formation and/or petal formation and/or controlled formation of abscission areas is integrated in a stable manner into the genome of plant cells or plant tissue and the plant cells or plant tissue thus obtained is regenerated to form plants. The invention also relates to plants and the seeds of plants which can be obtained according to the inventive method.
Patent AU-549917-B2 (AU)
Title: Magnetic locking pins for locks
Inventor: SEDLEY BRUCE S
IPC: E05B47/00
Filed: 1982-06-22
Granted: 1986-02-20
Abstract: The method starts from a magnet (14) having its opposite ends magnetized such that north and south pole be equally strong. One pole (N) of the locking magnet is connected to the opposite pole (S) of a second magnet (30). A magnetic field is applied to the opposite end (S) of the locking magnet, and is collapsed to reverse the polarity of said opposite end, whereby the strenght of the magnetic pole adjacent the second magnet becomes relatively weak compared to the pole adjacent the magnetic field. Use in order to prevent undesirable interaction between the locking magnets in magnetic locksets.
Patent AU-560141-B2 (AU)
Title: Piperazine derivatives of theophylline
Inventor: FAVIER COLETTE
IPC: C07D295/08
Filed: 1982-07-30
Granted: 1987-04-02
Abstract: New compounds of the formula   <IMAGE> (I)   <IMAGE>  and the pharmaceutically acceptable acid addition salts thereof, wherein M is selected from the group consisting of hydrogen, morpholino, benzylamino, di-n-lower alkylamine, n-lower alkylamine, and aryl piperazino; Z1 and Z2 are each independently selected from the group consisting of CH2, CHOB and C=O, wherein B is selected from the group consisting of hydrogen and alkanoyl; Y is oxygen or sulfur; n is an integer from 0-4 but cannot be zero when Z1 is CHOB; m is an integer from 0-4 but cannot be zero when Z2 is CHOB, or when m is hydrogen; R1, R2 and R3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy; and R4 and R5 are each independently lower alkyl, with the proviso that both R4 and R5 cannot be methyl when M is hydrogen; are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold. They are also vasodilators.
Patent AU-650494-B2 (AU)
Title: Non-chromated cobalt conversion coating
Inventor: SCHRIEVER MATTHIAS P
IPC: C23C22/58
Filed: 1991-11-27
Granted: 1994-06-23
Abstract: (A.) A process for forming a cobalt conversion coating on a metal substrate, thereby imparting corrosion resistance and paint adhesion properties. The invention was developed as a replacement for the prior art chromic acid process. The process includes the steps of: (a) providing a cobalt conversion solution comprising an aqueous solution having a pH of about 7.0 to 7.2 and containing a soluble cobalt-III hexacoordinated complex, the concentration of the cobalt-III hexacoordinated complex being from about 0.1 mole per gallon of solution to the saturation limit of the cobalt-III hexacoordinated complex; and (b) contacting the substrate with the solution for a sufficient amount of time, whereby the cobalt conversion coating is formed. The substrate may be aluminum or aluminum alloy, as well as magnesium and its alloys, Cd plated substrates, and Zn plated substrates. The cobalt-III hexacoordinated complex may be present in the form of Me3[Co(NO2)6] wherein Me is one or more of Na, K, and Li. (B.) A chemical conversion coating solution for producing the cobalt conversion coating on a metal substrate, the solution being an aqueous solution having a pH of about 7.0 to 7.2 and containing a soluble cobalt-III hexacoordinated complex, the concentration of the cobalt-III hexacoordinated complex being from about 0.1 mole per gallon of solution to the saturation limit of the cobalt-III hexacoordinated complex. The cobalt conversion solution may be prepared by a bath makeup sequence including the steps of: (a) dissolving a metal nitrite salt; (b) dissolving an accelerator such as NaI; (c) dissolving a cobalt-II salt; and (d) then adding an oxidizer such as H2O2. (C.) A coated article exhibiting corrosion resistance and paint adhesion properties, the article including: (a) a metal substrate; and (b) a cobalt conversion coating formed on the substrate, the cobalt conversion coating including aluminum oxide Al2O3 as the largest volume percent, and cobalt oxides CoO, Co3O4, and Co2O3. <IMAGE>
Patent AU-560838-B2 (AU)
Title: 2-fluoro alkyl thio 6 hydroxyethyl penems
Inventor: GIRIJAVALLABHAN VIYYOOR M
IPC: C07D499/00
Filed: 1982-11-22
Granted: 1987-04-16
Abstract: Disclosed herein are (5R,6S,8R)-6-(1-hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylic acid and the metabolisable esters thereof and alkali metal salts thereof, which are potent antibacterial agents.
Patent DE-1900518-B2 (DE)
Title: Resin spray system - with solvent flushing
IPC: B05B15/02
Filed: 1969-01-07
Abstract: Unaerated liquid catalyst and unaerated liquid resin are supplied by respective pumping devices under pressure via a mixing device to a discharge device for the mixture. A flushing solvent supply is connected to the mixing device to flush out the mixing and discharge devices. A trigger control is movable in one direction to allow mixing and discharge of the resin and catalyst and in a second direction to allow passage of the flushing solvent through the mixing and discharge devices.